Role of Metalloproteinases in Mucin Overproduction in COPD
金属蛋白酶在慢性阻塞性肺病粘蛋白过量产生中的作用
基本信息
- 批准号:7461274
- 负责人:
- 金额:$ 35.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcroleinAcuteAnimal ModelBindingBreathingCD44 geneCause of DeathCell physiologyCell-Free SystemCellsChronicChronic Obstructive Airway DiseaseCigaretteClara cellComplexConditionDominant-Negative MutationEnvironmental IrritantsEpidermal Growth FactorEpidermal Growth Factor ReceptorEpithelialEpithelial CellsEpitheliumErlotinibEventFamilyFutureGelatinase BGene ExpressionGene TargetingGenetic TranscriptionGoalsGrowth Factor ReceptorsHealthHumanIn VitroInterventionIrritantsKnowledgeLeadLigand BindingLigandsLung diseasesMAP Kinase GeneMMP9 geneMUC5AC geneMass Spectrum AnalysisMatrix MetalloproteinasesMeasuresMediatingMembraneMessenger RNAMetalloproteasesMolecularMucinsMucous body substanceMusPathway interactionsPhosphorylationPost-Translational Protein ProcessingProcessProductionProprotein ConvertasesProteinsReceptor ActivationReceptor InhibitionReceptor SignalingRegulationResearchResistanceRoleSignal PathwaySignal TransductionSmall Interfering RNASmokeTherapeuticTherapeutic InterventionTimeTissue Inhibitor of MetalloproteinasesTranscriptWorkairway epitheliumbasecigarette smoke-inducedcigarette smokingcigarette smokinghuman MMP14 proteinin vivoinhibitor/antagonistinnovationinsightintracellular protein transportpreventprotein transportresponse
项目摘要
DESCRIPTION (provided by applicant): Problem. Chronic obstructive pulmonary disease (COPD), the fourth leading cause of death, is clearly caused by cigarette smoking and other environmental irritants. One feature of COPD involves a phenotypic shift in the airway epithelium characterized by decreased ciliated and Clara cells and increased mucus producing cells. Importantly, irritants in cigarette smoke, particularly acrolein, can trigger these events. Although the possible roles of matrix metalloproteinases (MMPs) in COPD are well recognized, the mechanisms of how MMP-activation orchestrates a persistent change in epithelial cell function are uncertain. Thus, the overall objective of this proposal is to determine the molecular mechanisms activating MMPs/epithelial growth factor receptor (EGFR) signaling that in turn lead to persistent mucus overproduction. Hypothesis: Acrolein/cigarette smoke initially activates MMPs that increase mucin transcription. In addition, chronic exposure further stimulates transcription of MMPs, and represses transcription of tissue inhibitors of metalloproteinase. Combined, these immediate and delayed responses lead to persistent mucus production. Aims. To determine the molecular mechanisms controlling: 1) increased MMP14 activation/ expression in airway epithelial cells, 2) increased MMP9 activation/expression in airway epithelial cells, and 3) MMP14/MMP9/ EGFR-signaling in mucin production in mice. Significance. This proposal seeks to establish the mechanisms by which inhaled irritants activate signaling pathways that regulate mucin gene expression. At the completion of this project, we expect to obtain a better understanding of how acrolein or cigarette smoke 1) activates MMP14, 2) modifies cell signaling that controls persistent MMP9 transcription, 3) modulates acute and persistent mucin production in the airways of mice, and 4) generates a mechanism to persistent mucin production that can be prevented by proprotein convertase/ EGFR inhibition. PROJECT NARRATIVE. This research is significant and innovative because it will determine the mechanisms by which acrolein and cigarette smoke can activate matrix metalloproteinases (MMPs) and initiate events controlling persistent mucin production. At the completion of this project, we expect: 1) to obtain a better understanding of the mechanisms by which acrolein activates MMP14 in human airway epithelial cells, 2) to gain knowledge into the mechanism by which acrolein modifies cell signaling that controls persistent MMP9 production/activation and mucin production in vitro, 3) to identify the events modulated in acute and persistent mucin production in the airways of an animal model of cigarette smoke and acrolein exposure, and 4) to determine whether protein convertase/EGFR inhibitors can prevent the events that leads to persistent mucin production. The anticipated human health impact of this study is an evidence-based scientific verification or refutation of the likelihood that therapeutics directed at MMP14/MMP9/EGFR signaling can be considered for the treatment of mucus overproduction in COPD.
描述(由申请人提供):问题。慢性阻塞性肺病(COPD)是第四大死因,显然是由吸烟和其他环境刺激物引起的。 COPD 的一个特征涉及气道上皮的表型转变,其特征是纤毛细胞和克拉拉细胞减少以及粘液产生细胞增加。重要的是,香烟烟雾中的刺激物,特别是丙烯醛,可以引发这些事件。尽管基质金属蛋白酶 (MMP) 在 COPD 中的可能作用已得到广泛认可,但 MMP 激活如何协调上皮细胞功能持续变化的机制尚不确定。因此,该提案的总体目标是确定激活 MMP/上皮生长因子受体 (EGFR) 信号传导的分子机制,从而导致持续的粘液过量产生。假设:丙烯醛/香烟烟雾最初会激活 MMP,从而增加粘蛋白转录。此外,长期暴露会进一步刺激 MMP 的转录,并抑制金属蛋白酶组织抑制剂的转录。这些即时反应和延迟反应相结合,导致粘液持续产生。目标。确定控制以下的分子机制:1) 气道上皮细胞中 MMP14 激活/表达增加,2) 气道上皮细胞中 MMP9 激活/表达增加,以及 3) 小鼠粘蛋白产生中的 MMP14/MMP9/EGFR 信号传导。意义。该提案旨在建立吸入刺激物激活调节粘蛋白基因表达的信号通路的机制。该项目完成后,我们希望更好地了解丙烯醛或香烟烟雾如何 1) 激活 MMP14,2) 修改控制持久性 MMP9 转录的细胞信号传导,3) 调节小鼠气道中急性和持久的粘蛋白产生, 4) 产生一种持续产生粘蛋白的机制,可以通过抑制前蛋白转化酶/EGFR 来阻止这种机制。项目叙述。这项研究具有重要意义和创新性,因为它将确定丙烯醛和香烟烟雾激活基质金属蛋白酶(MMP)并启动控制持久粘蛋白产生的事件的机制。该项目完成后,我们期望:1) 更好地了解丙烯醛激活人气道上皮细胞中 MMP14 的机制,2) 了解丙烯醛修改控制持续 MMP9 产生的细胞信号传导的机制/体外激活和粘蛋白产生,3) 鉴定香烟烟雾和丙烯醛暴露的动物模型气道中急性和持续粘蛋白产生的调节事件,以及 4)确定蛋白转化酶/EGFR 抑制剂是否可以预防导致持续粘蛋白产生的事件。这项研究对人类健康的预期影响是基于证据的科学验证或驳斥针对 MMP14/MMP9/EGFR 信号传导的疗法可考虑用于治疗 COPD 粘液过度产生的可能性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George Douglas Leikauf其他文献
George Douglas Leikauf的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George Douglas Leikauf', 18)}}的其他基金
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的病理生理机制
- 批准号:
10708438 - 财政年份:2023
- 资助金额:
$ 35.32万 - 项目类别:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
提高我们对电子烟或电子烟产品使用相关肺损伤的机制理解
- 批准号:
10115186 - 财政年份:2020
- 资助金额:
$ 35.32万 - 项目类别:
Role of Metalloproteinases in Mucin Overproduction in COPD
金属蛋白酶在慢性阻塞性肺病粘蛋白过量产生中的作用
- 批准号:
7783818 - 财政年份:2008
- 资助金额:
$ 35.32万 - 项目类别:
Role of Metalloproteinases in Mucin Overproduction in COPD
金属蛋白酶在慢性阻塞性肺病粘蛋白过量产生中的作用
- 批准号:
7581036 - 财政年份:2008
- 资助金额:
$ 35.32万 - 项目类别:
Functional Genomics of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
- 批准号:
8144632 - 财政年份:2006
- 资助金额:
$ 35.32万 - 项目类别:
Functional Genomics of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
- 批准号:
8323241 - 财政年份:2006
- 资助金额:
$ 35.32万 - 项目类别:
Functional Genomics of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
- 批准号:
8485604 - 财政年份:2006
- 资助金额:
$ 35.32万 - 项目类别:
Functional Genomics of Chemical -Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
- 批准号:
7662563 - 财政年份:2006
- 资助金额:
$ 35.32万 - 项目类别:
相似国自然基金
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
建立脑内急性基因编辑的孤独症非人灵长类动物模型
- 批准号:
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:专项基金项目
染色体大片段缺失的急性髓性白血病动物模型的构建及分析
- 批准号:81770157
- 批准年份:2017
- 资助金额:84.0 万元
- 项目类别:面上项目
树鼩异种移植模型的建立及免疫排斥机制的深入研究
- 批准号:81771721
- 批准年份:2017
- 资助金额:80.0 万元
- 项目类别:面上项目
自发性高甘油三酯急性胰腺炎大鼠模型的建立及应用
- 批准号:81570584
- 批准年份:2015
- 资助金额:85.0 万元
- 项目类别:面上项目
相似海外基金
Cellular and molecular mechanisms of e-cigarette vaping-induced acute lung injury
电子烟引起急性肺损伤的细胞和分子机制
- 批准号:
10690279 - 财政年份:2022
- 资助金额:
$ 35.32万 - 项目类别:
BLR&D Research Career Scientist Award Application (Renewal)
BLR
- 批准号:
10618192 - 财政年份:2021
- 资助金额:
$ 35.32万 - 项目类别:
BLR&D Research Career Scientist Award Application (Renewal)
BLR
- 批准号:
10373048 - 财政年份:2021
- 资助金额:
$ 35.32万 - 项目类别:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
提高我们对电子烟或电子烟产品使用相关肺损伤的机制理解
- 批准号:
10115186 - 财政年份:2020
- 资助金额:
$ 35.32万 - 项目类别:
Advanced TRPA1 Inhibitor for the Treatment of Chlorine Inhalation Injury
用于治疗氯吸入损伤的先进 TRPA1 抑制剂
- 批准号:
10247523 - 财政年份:2019
- 资助金额:
$ 35.32万 - 项目类别: